当前位置: 首页 > 医疗版 > 疾病专题 > 心血管科 > 心力衰竭
编号:13505767
冠心病心力衰竭采用美托洛尔联合曲美他嗪治疗方式观察临床疗效
http://www.100md.com 2020年2月15日 《中西医结合心血管病电子杂志》 20205
     【摘要】目的 探讨冠心病患者接受阿托伐他汀联合曲美他嗪治疗的临床疗效。方法 采用随机方法将2017年我院诊治的94例冠心病患者分为2组,对照组使用阿托伐他汀治疗,观察组采用阿托伐他汀联合曲美他嗪治疗,比较2组的治疗效果。结果 治疗后2组患者的临床指标均明显改善,观察组的改善幅度更大,对比差异性显著,差异有统计学意义(P<0.05)。观察组治疗的总有效率为95.7%,显著高于对照组的76.6%,组间比较,差异有统计学意义(P<0.05)。结论 阿托伐他汀联合曲美他嗪用于冠心病治疗的效果良好,可明显降低患者的血脂水平,减轻心绞痛,强化心功能,可临床采纳和推广。

    【关键词】冠心病;阿托伐他汀;曲美他嗪

    【中图分类号】969.4 【文献标识码】A 【文章编号】ISSN.2095.6681.2020.5..02

    【Abstract】objective To investigate the clinical effect of Atto vastatin combined with trimetazidine in patients with coronary heart disease.Methods A total of 94 patients with coronary heart disease in 2017 were randomly divided into two groups.The control group was treated with Atto vastatin and the observation group was treated with Atto vastatin combined with trimetazidine.Results The clinical indexes of the two groups were significantly improved after treatment ......

您现在查看是摘要页,全文长 4771 字符